← Eichor
Study identifier: NCT04584632 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

Condition: Peripheral Arterial Disease · Vascular Diseases · Stenosis  ·  Sponsor: Efemoral Medical, Inc.

PhaseNA
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

To evaluate the safety and performance of the EVSS in patients with symptomatic peripheral vascular disease from stenosis or occlusion of the femoropopliteal artery

This description comes directly from the study's public registry record.

Talk to the study team

Lew Schwartz, MD  ·  224-707-2601  ·  lewis.schwartz@efemoralmedical.com

Always discuss trial participation with your own doctor first.

Locations (8)

Northern HealthSydney, New South Wales, AustraliaRecruiting
Canberra HospitalCanberra, AustraliaRecruiting
The Alfred HospitalMelbourne, AustraliaRecruiting
Prince Of Wales HospitalSydney, AustraliaRecruiting
Royal North ShoreSydney, AustraliaRecruiting
Auckland City HospitalAuckland, New ZealandRecruiting
Christchurch HospitalChristchurch, New ZealandRecruiting
Waikato HospitalHamilton, New ZealandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04584632